Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy.

European journal of neurology2007Láinez MJ, Galván J, Heras J, et al.

Study designRandomized controlled trial

SubjectHuman

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

Acute DiseaseAdultCaffeineCross-Over StudiesDouble-Blind MethodDrug Therapy, CombinationErgotamineFemaleHumansMaleMigraine DisordersNauseaPatient SatisfactionPhosphodiesterase InhibitorsPhotophobiaSerotonin Receptor AgonistsTreatment OutcomeTryptaminesVasoconstrictor Agents

DOI 10.1111/j.1468-1331.2006.01594.x

PMID 17355546

View source →